Product image of Mitforgen (Metformin Hydrochloride) supplied by GNH India

Mitforgen

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Mitforgen (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Mitforgen, is a Biguanide presented as an oral formulation for oral use. It improves blood glucose control in adults with type 2 diabetes mellitus by reducing hepatic glucose production and increasing peripheral insulin sensitivity. Mitforgen complies with European Union quality standards and is supplied as tablets for once‑ or twice‑daily dosing as prescribed.

GNH India supplies Mitforgen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide through reliable logistics and regulatory support.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mitforgen (metformin hydrochloride) is a biguanide antidiabetic that lowers blood glucose by targeting insulin resistance and hepatic glucose output.

  • Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
  • Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes.
  • Polycystic ovary syndrome (off‑label): reduces insulin resistance and may improve menstrual regularity.

How It Works

  • Metformin hydrochloride acts primarily on the liver, where it inhibits mitochondrial respiratory‑chain complex I, leading to decreased gluconeogenesis. It also enhances peripheral glucose uptake by activating AMP‑activated protein kinase (AMPK), which improves insulin sensitivity in muscle and adipose tissue. The combined effect reduces endogenous glucose production and increases utilization, resulting in lower plasma glucose concentrations without stimulating insulin secretion.

Side Effects

Metformin may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, and diarrhea.
  • Metallic taste: transient alteration in taste perception.
  • Weight loss: modest reduction in body weight.
  • Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects

  • Lactic acidosis: rare but life‑threatening metabolic disturbance.
  • Severe hypoglycemia: uncommon, usually when combined with other glucose‑lowering agents.
  • Hepatotoxicity: very rare liver injury.
  • Skin reactions: severe rash or Stevens‑Johnson syndrome.

Precautions & Warnings

Before initiating Mitforgen, clinicians should evaluate several safety considerations to minimize risk.

  • Renal function: assess creatinine clearance and avoid use in severe renal impairment.
  • Lactic acidosis risk: monitor for unexplained fatigue, myalgia, or respiratory distress.
  • Alcohol consumption: limit intake as it may increase lactic acidosis risk.
  • Surgical procedures or iodinated contrast: withhold metformin temporarily around the time of the procedure.
  • Pregnancy and breastfeeding: use only if potential benefit outweighs risk; consult obstetric guidance.
  • Store at ambient temperature: keep tablets in the original container, protect from moisture and heat.

Avoid Interactions

Metformin can interact with several medicines, altering its plasma levels or increasing adverse effect potential.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate lactic acidosis; discontinue metformin before and after exposure.
  • Cimetidine: inhibits renal tubular secretion, raising metformin concentrations.
  • Alcohol: excessive intake heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: can mask hypoglycemia symptoms.
  • Diuretics (especially thiazides): may affect renal function and metformin clearance.
  • ACE inhibitors or ARBs: monitor renal function when combined.
  • Oral contraceptives: may modestly increase metformin levels.

Frequently Asked Questions

Mitforgen contains metformin hydrochloride, an oral antidiabetic medication indicated for the management of type 2 diabetes mellitus. It helps lower elevated blood glucose levels by improving the body’s response to insulin and reducing glucose production in the liver.

Metformin hydrochloride reduces hepatic glucose output by inhibiting mitochondrial respiratory‑chain complex I and activates AMP‑activated protein kinase (AMPK) in muscle and fat cells. This dual action decreases new glucose formation and increases peripheral glucose uptake, leading to lower blood sugar without stimulating insulin release.

The appropriate dose of Mitforgen is individualized by the prescribing healthcare professional. Dosage decisions consider factors such as the patient’s current glycemic control, renal function, age, weight, and any concomitant medications, ensuring safe and effective therapy.

Metformin is classified as a pregnancy‑category drug only when the potential benefit justifies the potential risk to the fetus. It may be continued during pregnancy if deemed necessary by a physician. While small amounts are excreted in breast milk, breastfeeding is generally considered acceptable when the infant is monitored closely.

To request Mitforgen, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with sulfonylureas, Mitforgen does not stimulate insulin secretion, reducing the risk of hypoglycemia. Unlike insulin therapy, it is taken orally and does not require injection. Its primary advantage is improving insulin sensitivity and lowering hepatic glucose output, making it a first‑line option for many patients with type 2 diabetes.

Mitforgen tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Mitforgen is taken orally, usually with meals to lessen gastrointestinal discomfort. The tablet is swallowed whole with a full glass of water. The prescribing clinician determines the exact dosing schedule, which may be once or twice daily based on individual therapeutic response.

The most serious potential adverse effect of Mitforgen is lactic acidosis, a rare but life‑threatening condition characterized by rapid breathing, muscle pain, and abdominal discomfort. Severe hypoglycemia can also occur, particularly when combined with other glucose‑lowering agents. Prompt medical attention is required if these symptoms arise.

Mitforgen is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and those who have experienced lactic acidosis while on metformin. Caution is also advised for individuals with hepatic disease or significant heart failure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT